Lakshmi Srivaths

Lakshmi Srivaths

Auto-generated profile, based on publicly available information

Lakshmi Srivaths

Gulf States Hemophilia & Thrombophilia Center, McGovern Medical School at UT Health Houston, Houston, Texas

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
LSLakshmi V. Srivaths
Lakshmi V. Srivaths
JDJennifer E. Dietrich
Jennifer E. Dietrich
DYDonald L. Yee
Donald L. Yee
HSHaleh Sangi-Haghpeykar
Haleh Sangi-Haghpeykar
DMDonald Mahoney
Donald Mahoney

1 May 2016 in Thrombosis Research
Verified
Journal Article
Closed access
TITitilope Ishola
Titilope Ishola
SKSusan E. Kirk
Susan E. Kirk
DGDanielle Guffey
Danielle Guffey
KVKatherine Voigt
Katherine Voigt
MSMona D. Shah
Mona D. Shah
LSLakshmi Srivaths
Lakshmi Srivaths

20 November 2013 in Haemophilia
Verified
Journal Article
Closed access
PDF file
HMH. L. Mills
H. L. Mills
MAM. S. Abdel‐Baki
M. S. Abdel‐Baki
JTJ. Teruya
J. Teruya
JDJ. E. Dietrich
J. E. Dietrich
MSM. D. Shah
M. D. Shah
LSL. V. Srivaths
L. V. Srivaths

14 July 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
LSLakshmi Srivaths
Lakshmi Srivaths
CMCharles G. Minard
Charles G. Minard
SOSarah H. O’brien
Sarah H. O’brien
AWAllison P. Wheeler
Allison P. Wheeler
EMEric Mullins
Eric Mullins
PKPeter A. Kouides
Peter A. Kouides
Low von Willebrand factor (VWF) in adults is associated with significant bleeding, most notably heavy menstrual bleeding (HMB) and postpartum hemorrhage, although this has not been characterized in adolescents. The objectives of this analysis of a multicenter single arm observational cohort study in adolescents with low VWF–associated HMB were to describe the bleeding phenotype, HMB severity, and related complications. Eligibility criteria included postmenarchal females 100) and low VWF (2 values of VWF activity ≥30 and ≤50 IU/dL). Patients diagnosed with other bleeding disorders were ineligible. Clinical phenotype data, including PBAC and Bleeding Assessment Tool (BAT) scores, laboratory data, and HMB management/outcome details, were extracted. Patient demographics and clinical characteristics were summarized as medians with minimum/maximum values or frequencies with percentages. Groups were compared using a Wilcoxon rank-sum test or Fisher’s exact test. A total of 113 patients met inclusion criteria, and 2 were excluded. Ninety four percent had a significant bleeding phenotype (BAT score >2), with predominantly mucocutaneous bleeding (32%-44%), postprocedural/surgical bleeding (15%), and severe HMB (BAT HMB domain score ≥2; 90%). Bleeding complications included iron deficiency (60%), anemia (21%), transfusion (12%), and hospitalization (10%). Desmopressin challenge response in subjects tested was good and sustained. Several (48%) required combined therapy for HMB (hormonal/hemostatic), and one third did not show improvement despite therapy. Our results suggest that adolescent females with low VWF have a significant bleeding phenotype and resultant complications warranting a focus on prompt diagnosis, appropriate therapy, and prevention of complications.

5 September 2017 in Haemophilia
Verified
Journal Article
Closed access
PDF file
LSL. V. Srivaths
L. V. Srivaths
QZQ. C. Zhang
Q. C. Zhang
VBV. R. Byams
V. R. Byams
JDJ. E. Dietrich
J. E. Dietrich
AJA. H. James
A. H. James
TIthe Hemophilia Treatment Centers Network Investigators
the Hemophilia Treatment Centers Network Investigators

9 July 2016 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Closed access
LSLakshmi Srivaths
Lakshmi Srivaths
JDJennifer E. Dietrich
Jennifer E. Dietrich
Venous thromboembolism (VTE) in adolescents is a serious condition that requires prompt recognition and optimal management to prevent mortality and long-term morbidity. Adolescents account for a large proportion of cases of VTE in children. As teenagers transition from childhood to adulthood, they are at risk of developing medical conditions and exposure to risky habits that predispose them to VTE. This review focuses on the variety of risk factors and comorbidities seen in adolescent VTE and takes a quick look into risk-based preventive strategies for primary and secondary prevention.